Myelodysplastic syndrome with erythroid hypoplasia is a new clinical entity responsive to cyclosporin A therapy.
Shimamoto
Takashi
T
Ohyashiki
Kazuma
K
D001854:Bone Marrow Cells / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use*; D004912:Erythrocytes / Q000473:pathology*; D015321:Gene Rearrangement; D006402:Hematologic Diseases / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000453:epidemiology; D013234:Stem Cells; D013601:T-Lymphocytes / Q000378:metabolism; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine